chr1-83906356-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024686.6(TTLL7):āc.2100T>Gā(p.Asp700Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,612,350 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_024686.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTLL7 | NM_024686.6 | c.2100T>G | p.Asp700Glu | missense_variant | 17/21 | ENST00000260505.13 | NP_078962.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTLL7 | ENST00000260505.13 | c.2100T>G | p.Asp700Glu | missense_variant | 17/21 | 2 | NM_024686.6 | ENSP00000260505.8 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152098Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250632Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135446
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1460252Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 726446
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152098Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74304
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 01, 2024 | The c.2100T>G (p.D700E) alteration is located in exon 17 (coding exon 16) of the TTLL7 gene. This alteration results from a T to G substitution at nucleotide position 2100, causing the aspartic acid (D) at amino acid position 700 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at